AHMEDABAD, India, Jan. 2, 2025
/PRNewswire/ -- Veeda Group has unveiled a new
logo and brand identity—Veeda Lifesciences—marking a key milestone
in its journey. The new brand name reflects the evolution from a
generics-focused Contract Research Organization (CRO) to a drug
development services enterprise for different modalities of drugs
including generics and novel chemical and biological entities.
Veeda Lifesciences will operate through four Strategic Business
Units: Clinical Trials, Healthy Volunteer Services, Biopharma
Services, and Preclinical & Non-Clinical Testing Services,
making Veeda an integrated research service provider.
Veeda Lifesciences represents the brand
that integrates Veeda Clinical Research, Health Data Specialists,
and Bioneeds India, showcasing research services across various
stages of the drug development value chain from discovery and
preclinical to late-phase development. The new identity reflects
the transition from generics to innovation, local to global, and
small molecules to biologics. Veeda Lifesciences is transitioning
to a CRO-CDMO model, while leveraging AI & Real-world
data.
Dr. Mahesh
Bhalgat, Group CEO and Managing Director of Veeda
Lifesciences, stated, "The name – Veeda
Lifesciences – and the new logo, designed to be modern and dynamic,
symbolize the Group's forward-thinking approach and dedication to
its core values and mission. It adds aspirational value to our
growth and vision for the future, striving for innovation,
excellence, and client satisfaction. We continue to diversify our
base offering services serving the growing needs of our
clients."
Founded in India in 2004, Veeda Lifesciences now operates
out of 5 countries while conducting trials in 26 geographies. The
strategic acquisition of Bioneeds in 2021 expanded Veeda into
preclinical services. Today, Veeda Lifesciences offers a broad
range of services to the life sciences and healthcare industries,
with reputable sponsors, including leading global pharma companies.
Veeda Lifesciences is now organized under four strategic business
units. The Clinical trials business comprises of Veeda's operations
in Europe (originally Health Data
Specialists) and patient-based clinical trials in India. The Healthy Volunteer Services includes
operations in Gujarat (India)
including clinical bioanalysis for small molecules. The Biopharma
services in Bengaluru (India)
include analytical characterization and functional characterization
of biologics along with cell line and process development and
clinical bioanalysis of large molecules. The preclinical testing
services of Veeda, based in Karnataka (India) includes our discovery research
services in the area of chemistry and biology.
About Veeda Lifesciences:
Veeda Lifesciences platform providing full
service as well as functional service for all the stages of drug
development to support biotech and pharmaceutical companies with
capabilities ranging from Pre-Clinical to Clinical Pharmacology and
Clinical Trials across different modalities. We support multiple
therapeutic domains and accelerate pipelines through advanced
real-world data capabilities on an AI platform. Committed to
quality with sound scientific capabilities, we continuously invest
in people and technology, to help clients in developing innovative
therapies and generic drugs for patients worldwide.
Disclaimer:
Veeda Clinical Research Limited (the
"Company") is proposing, subject to receipt of requisite
approvals, market conditions and other considerations, a public
issue of its equity shares in the near future and is in the process
of filing a draft red herring prospectus with the Securities and
Exchange Board of India. This
document is not an offer of securities for sale in the United States. Securities may not be
offered or sold in the United
States absent registration or an exemption from
registration. Any public offering of securities to be made in
the United States will be made by
means of a prospectus that may be obtained from the Company and
will contain detailed information about the Company and management,
as well as financial statements. The Company does not intend to
register any part of the offering in the
United States.
Logo:
https://mma.prnewswire.com/media/2589459/Veeda_Lifesciences_Logo.jpg
View original content to download
multimedia:https://www.prnewswire.com/news-releases/veeda-group-rebrands-as-veeda-lifesciences-302341174.html
SOURCE Veeda Lifesciences
